This revealed that pathways related to IL-2, CD4+ T cell memory formation and stimulation of CD8+ T were enriched in tumor-infiltrating T cells treated with hsBCL9CT-24 (Supplementary Fig. 8a, c). This evidence concerns the gene CD8A and neoplasm.